• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Protein tyrosine kinases in malignant melanoma.

作者信息

Easty D J, Bennett D C

机构信息

Department of Pathology, University College Dublin, Ireland.

出版信息

Melanoma Res. 2000 Oct;10(5):401-11. doi: 10.1097/00008390-200010000-00001.

DOI:10.1097/00008390-200010000-00001
PMID:11095400
Abstract

Protein tyrosyl phosphorylation is an essential component in intracellular signalling, with diverse and crucial functions including mediation of cell proliferation, survival, death, differentiation, migration and attachment. It is regulated by the balance between the activities of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases. A number of PTKs are encoded by proto-oncogenes or viral oncogenes, and are thus strongly implicated in cancer. While a role for PTKs in human melanoma is less firmly established, human melanomas or melanoma cells have been reported to contain more tyrosine phosphate than normal melanocytes, and some receptor PTKs (EPH-A2/ ECK and EPH-B3) are overexpressed in over 90% of melanoma cell lines. Other specific PTKs are also frequently overexpressed, including KDR and fibroblast growth factor receptor-4 (FGF-R4), while, interestingly, yet others, such as KIT and FES, are consistently downregulated in melanoma cell lines. All of these differentially expressed PTKs are candidates for gene products important in melanoma development. In addition, PTKs expressed in significant amounts in both benign and malignant melanocytes, such as insulin-like growth factor-1 receptor (IGF1-R), FGF-R1, HER2/NEU and FAK, are likely to play a role in melanoma genesis and progression.

摘要

相似文献

1
Protein tyrosine kinases in malignant melanoma.
Melanoma Res. 2000 Oct;10(5):401-11. doi: 10.1097/00008390-200010000-00001.
2
Tyrosine phosphate in melanoma progression.黑色素瘤进展中的酪氨酸磷酸化
Br J Dermatol. 2003 Aug;149(2):289-95. doi: 10.1046/j.1365-2133.2003.05405.x.
3
Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.黑色素瘤进展和转移过程中异常的蛋白酪氨酸激酶基因表达。
Int J Cancer. 1995 Jan 3;60(1):129-36. doi: 10.1002/ijc.2910600119.
4
Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
J Invest Dermatol. 1993 Nov;101(5):679-84. doi: 10.1111/1523-1747.ep12371675.
5
c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.c-Kit激酶在正常人类黑素细胞中响应肥大细胞生长因子时诱导一系列蛋白质酪氨酸磷酸化,并刺激丝裂原活化蛋白激酶,但在黑色素瘤中表达下调。
Mol Biol Cell. 1992 Feb;3(2):197-209. doi: 10.1091/mbc.3.2.197.
6
Receptor tyrosine kinases and their activation in melanoma.受体酪氨酸激酶及其在黑色素瘤中的激活。
Pigment Cell Melanoma Res. 2011 Jun;24(3):446-61. doi: 10.1111/j.1755-148X.2011.00836.x. Epub 2011 Mar 3.
7
Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes.正常和恶性黑素细胞中的生长因子、受体激酶和蛋白酪氨酸磷酸酶。
J Immunother (1991). 1992 Oct;12(3):154-61. doi: 10.1097/00002371-199210000-00002.
8
Protein tyrosine phosphatase genes downregulated in melanoma.在黑色素瘤中下调的蛋白质酪氨酸磷酸酶基因。
J Invest Dermatol. 2001 Nov;117(5):1255-60. doi: 10.1046/j.0022-202x.2001.01534.x.
9
Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.激酶缺陷型成纤维细胞生长因子受体1对人黑素瘤细胞自分泌细胞增殖及肿瘤发生以及成纤维细胞生长因子转化的成纤维细胞的抑制作用:Src家族激酶参与的证据
Oncogene. 1997 Jun 26;14(25):2999-3009. doi: 10.1038/sj.onc.1201159.
10
Growth factors and tyrosine protein kinases in normal and malignant melanocytes.正常和恶性黑素细胞中的生长因子与酪氨酸蛋白激酶
Cancer Metastasis Rev. 1991 Jun;10(2):129-40. doi: 10.1007/BF00049410.

引用本文的文献

1
Cytotoxic effect of Ad-ephrinA1-caspase-3-T on breast cancer cells .腺病毒介导的肾上腺素A1-半胱天冬酶-3-T对乳腺癌细胞的细胞毒性作用
Transl Cancer Res. 2019 Feb;8(1):104-110. doi: 10.21037/tcr.2019.01.07.
2
Esophageal carcinoma cell-excreted exosomal uc.189 promotes lymphatic metastasis.食管癌细胞分泌的外泌体 uc.189 促进淋巴转移。
Aging (Albany NY). 2021 May 23;13(10):13846-13858. doi: 10.18632/aging.202979.
3
Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation.
高美辛通过操纵控制细胞死亡和增殖的关键信号级联来抑制黑色素瘤的生长。
Sci Rep. 2018 Aug 1;8(1):11519. doi: 10.1038/s41598-018-29826-4.
4
Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines.吉非替尼或拉帕替尼与福瑞替尼协同诱导黑色素瘤细胞系产生细胞毒性作用。
Oncotarget. 2018 Apr 6;9(26):18254-18268. doi: 10.18632/oncotarget.24810.
5
Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.硫酸乙酰肝素蛋白聚糖(HSPGs-多配体蛋白聚糖)在霍奇金淋巴瘤发病机制中的自分泌和旁分泌生长因子信号传导中的分子作用研究
Tumour Biol. 2016 Sep;37(9):11573-11588. doi: 10.1007/s13277-016-5118-7. Epub 2016 Jun 18.
6
Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas.组合药物筛选和分子谱分析揭示了V600E BRAF突变型黑色素瘤对BRAF抑制的内在和适应性耐药的多种机制。
Oncotarget. 2016 Jan 19;7(3):2734-53. doi: 10.18632/oncotarget.6548.
7
Preclinical and clinical development of siRNA-based therapeutics.基于小干扰RNA的治疗药物的临床前和临床开发。
Adv Drug Deliv Rev. 2015 Jun 29;87:108-19. doi: 10.1016/j.addr.2015.01.007. Epub 2015 Feb 7.
8
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.miRNA 和 siRNA 在卵巢癌治疗中的治疗协同作用。
Cancer Discov. 2013 Nov;3(11):1302-15. doi: 10.1158/2159-8290.CD-13-0159. Epub 2013 Sep 3.
9
Structural and functional properties of platelet-derived growth factor and stem cell factor receptors.血小板衍生生长因子和干细胞因子受体的结构和功能特性。
Cold Spring Harb Perspect Biol. 2013 Aug 1;5(8):a009100. doi: 10.1101/cshperspect.a009100.
10
A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3.高内涵细胞衰老筛选鉴定候选肿瘤抑制因子,包括 EphA3。
Cell Cycle. 2013 Feb 15;12(4):625-34. doi: 10.4161/cc.23515. Epub 2013 Jan 16.